15/01/2016
Parc Tecnològic del Vallès: Arrival of FERRER and Accreditation of SEVIBE CELLS
Parc Tecnològic del Vallès: Arrival of FERRER and Accreditation of SEVIBE CELLS
The Parc Tecnològic del Vallès (PTV) is the oldest technology park in Spain (1987). PTV can be considered as the initial phase of a more global project of a territory designed to attract innovative companies in the environment of the Universitat Autònoma de Barcelona. This project has matured with the second phase corresponding to the creation of the Barcelona Synchrotron Park (BSP) around the ALBA synchrotron operative since 2012.
With 133 companies (2,760 employees, total turnover of 845 million euros), PTV recently received two good news from the healthcare sector:
On one hand, FERRER pharmaceutical multinational company has started activities in PTV with the creation of a research center devoted to new technologies for medication administration.
On the other hand, SEVILLE CELLS, which is already settled in PTV, has received the AABB accreditation (American Association of Blood Banks) and therefore becomes the 5th blood and tissue bank among the 117 banks in Europe (the first one in Spain) to be internationally certified for cell therapy. It can be mentioned that the FAMICORD European group to which SEVIBE CELLS belongs already carried out 127 cord blood stem cells transplants, making it the leader in Europe.
With 133 companies (2,760 employees, total turnover of 845 million euros), PTV recently received two good news from the healthcare sector:
On one hand, FERRER pharmaceutical multinational company has started activities in PTV with the creation of a research center devoted to new technologies for medication administration.
On the other hand, SEVILLE CELLS, which is already settled in PTV, has received the AABB accreditation (American Association of Blood Banks) and therefore becomes the 5th blood and tissue bank among the 117 banks in Europe (the first one in Spain) to be internationally certified for cell therapy. It can be mentioned that the FAMICORD European group to which SEVIBE CELLS belongs already carried out 127 cord blood stem cells transplants, making it the leader in Europe.
More news
23/03/2020
ICN2 and CReSA at the forefront against COVID-19
10/03/2020
Barcelona Synchrotron Park publishes a guide to promote biodiversity in its buildings
27/02/2020
Batteries of the future are investigated in the ALBA synchrotron
10/02/2020
With Solar Orbiter, SENER approaches a star
27/01/2020
Welcome, Natura Bissé!
14/01/2020
The Alba Synchrotron has lots of tricks up its sleeve!
home